Cargando…
MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3
Recent studies have revealed a pivotal role of microRNAs (miRs) in regulating the initiation and development of multiple types of cancer. In the present study, it was discovered that miR-382 may be an important tumor suppressor in non-small cell lung cancer (NSCLC). It was demonstrated that miR-382...
Autores principales: | Chen, Dingzhu, Zhang, Yi, Lin, Yong, Shen, Feimin, Zhang, Zhijian, Zhou, Jiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425134/ https://www.ncbi.nlm.nih.gov/pubmed/30906428 http://dx.doi.org/10.3892/etm.2019.7271 |
Ejemplares similares
-
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1
por: Ren, Yupeng, et al.
Publicado: (2018) -
MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2
por: Liu, Jiangtao, et al.
Publicado: (2019) -
MicroRNA-382-5p inhibits osteosarcoma development and progression by negatively regulating VEZF1 expression
por: Wu, Hui, et al.
Publicado: (2021) -
Clinical significance and prognostic role of hypoxia-induced microRNA 382 in gastric adenocarcinoma
por: Seo, An Na, et al.
Publicado: (2019) -
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
por: Xu, Meng, et al.
Publicado: (2014)